Monoclonal antibody IgG2a

Monoclonal antibody IgG2a

C025/4131 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 57.2MB

Downloadable file size: 6.8MB

Price image Pricing

Please login to use the price calculator


Credit: ALFRED PASIEKA/SCIENCE PHOTO LIBRARY

Caption: Antibody molecule. Molecular structure of a monoclonal human immunoglobulin (IgG2a). IgG antibodies are composed of 2 long heavy chains and 2 shorter light chains. This antibody adopts a T-shape: the arms of the T make up the Fab or antigen binding region, while the base part or Fc region plays a role in interacting with the immune system. Under the name of Denosumab this type of human monoclonal antibody is used for the treatment of osteoporosis, treatment-induced bone loss and bone metastases. Medication trade names include Prolia and Xgeva

Release details: Model release not required. Property release not required.

Keywords: antibodies, antibody, bone, brittle bone disease, cancellous bone, condition, denosumab, disease, disorder, fracture, healthcare, igg2, igg2a, immune, immune system, immunity, immunoglobulin, immunoglobulins, immunological, immunology, leucocyte, leucocytes, leukocyte, leukocytes, loss, medical, medication, medicine, menopausal, menopause, metastases, monoclonal antibody, oestrogen, osteoporosis, prolia, protein, proteins, proteomics, removal, spongy, spongy bone, system, treatment, xgeva, y-shaped

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.